Close to 50% of new drugs coming to market qualify as specialty drugs. By definition, the cost runs to several hundreds of dollars a month. Some cost more than $100,000 per dose. The rising cost is a concern to plan sponsors and members who bear these diagnoses. When members cannot afford their pharmacy copay, they may decline to participate in treatment, risking further medical complications and higher plan costs.
Our integrated approach to high-cost drug management includes Copay Maximizer, which can help members AND plan sponsors save a significant amount of money. Watch this video to learn more!